
Thank you to everyone who joined us for a successful Third Annual Wednesday Liver Symposium! We appreciate everyone who attended and helped make this such a great meeting. @DrLoomba

Dawn of a New Era in Precision Medicine

Thank you to everyone who joined us for a successful Third Annual Wednesday Liver Symposium! We appreciate everyone who attended and helped make this such a great meeting. @DrLoomba


Happening Now! 🎤 The Precision Medicine Liver Symposium is in full swing packed with dynamic discussions, new data, and expert perspectives driving progress in liver disease management.


There’s still time to register for the Thursday Liver Symposium! Hear from Dr. Naga Chalasani as he dives into cutting-edge topics including PNPLA3, Resmetirom, FGF-21, and GLP-1 analogues—and what they mean for liver disease management. 👉 Register: loom.ly/YkVFD6Y

Join us at the Thursday Liver Symposium for an expert session with Dr. Naim Alkhouri, MD, FAASLD, DABOM — “Event Rate in MASH Cirrhosis Trials by VCTE: Assessment of the Phase 3 Trial Landscape.” Register: loom.ly/YkVFD6Y

Dr. Rohit Loomba leads Second Annual Thursday Liver Symposium on November 6th - Register Now!: loom.ly/YkVFD6Y @DrLoomba

🔥 Debate Spotlight : Should patients with burnt-out NASH be included in cirrhosis trials? Don’t miss this thought-provoking session as two leading experts go head-to-head on one of the most important questions in liver research. 👉 Register now: loom.ly/YkVFD6Y

Register now for the Second Annual Thursday Liver Symposium on Thursday, November 6th! Don’t miss Dr. Rohit Loomba as he presents new data on cT1, MRE, and MRI-PDFF in treatment response. @DrLoomba 👉 Secure your spot now!: loom.ly/FOeLWak

Don’t miss this session at the Thursday Liver Sympo! 📢 Guadalupe Garcia-Tsao, MD, FRCP will break down the key NEJM papers on SLD and cirrhosis, highlighting the latest evidence and what it means for patient care. 👉 Seats are limited—register now at loom.ly/YkVFD6Y

Learn from the experts at the Second Annual Thursday Liver Symposium! Cutting-edge updates, practical strategies, and leading voices in liver care—all in one event. Register now: loom.ly/YkVFD6Y

Join us in Washington, DC! The Second Annual Thursday Liver Symposium takes place November 6th. Don’t miss this opportunity to connect, learn, and advance care in liver disease. 👉 loom.ly/YkVFD6Y

Dr. Rohit Loomba leads the Second Annual Thursday Liver Symposium on November 6th - Register Now!: loom.ly/YkVFD6Y

Kick starting @MetALDconf in San Diego how to diagnose metALD in clinic ? @AjmeraVeeral @AASLDtweets @AmerGastroAssn @QAnstee @AleksanderKrag

Great talk @juanpabloarab on the impact of alcohol use in the natural history of SLD at the @MetALDconf . Assessment of alcohol intake over time should be standardized in clinical practice. @VCU @VCU_Liver @DrLoomba @MarcoArreseMD @rabataller @ArunJSanyalVCU

Pros and cons of current NITs in MetALD. Inflammation, excess weight, alcohol use and low specificity are the main caveats of NITs. Fantastic talk from @MajaThiele at the @MetALDconf ! #LiverTwitter @DrLoomba @AleksanderKrag @EASLedu @EASLnews @MASLDResearch